Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $474,891.00 |
|---|---|
| Enterprise Value | $733,227.00 |
| Earnings per Share | $0 |
| Beta | 0.79 |
| Outstanding Shares | 1,582,973,447 |
| P/E Ratio | -2.47 |
|---|---|
| PEG | 2.57 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -44.55 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | -2.3 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents...